Zolmitriptane as Prophylaxis for Chilhood Migraine

Last updated: October 13, 2023
Sponsor: Tanta University
Overall Status: Active - Recruiting

Phase

4

Condition

Oral Facial Pain

Headaches

Pain (Pediatric)

Treatment

zolmitriptanee

Valproate

topiramate

Clinical Study ID

NCT06089356
Migraine
  • Ages 8-18
  • All Genders

Study Summary

zolmitriptane can be tried as prophylactic therapy of childhood migraine

Eligibility Criteria

Inclusion

Inclusion Criteria: children with migraine -

Exclusion

Exclusion Criteria: those who suffer from ischemic heart disease , or who have allergy to any of drugs used

Study Design

Total Participants: 90
Treatment Group(s): 3
Primary Treatment: zolmitriptanee
Phase: 4
Study Start date:
January 01, 2023
Estimated Completion Date:
January 01, 2024

Study Description

90 children with migraine included in the study first group 30 received zolmitriptane second group 30 received topiramate third group 30 received valproate

Connect with a study center

  • Kafrelsheikh University

    Tanta, Kafrelsheikh
    Egypt

    Active - Recruiting

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.